NFTRH+; 2 Medical Companies, 2 Bottoming Patterns

These are speculative stocks and I ask that you research them yourself if at all interested, even in a trade.  This update simply notes two bottoming patterns, one activated and one not yet activated.

AFFX (genetic analysis, less speculative) served up losses to investors in 2015 and with Tax Loss season behind us could be setting up for a nice bounce.  The stock is tentatively above resistance and if that holds (the breakout was tested today) the pattern measures to a resistance area around 11.40.


Buy Target:  a hold above the resistance line, now being turned to tentative support.

Sell Target:  11.40 or anywhere lower that profit is acceptable.

Stop Loss:  a loss of support (red dotted line) below 9.60 (strict) or a loss of the MA 50s below 9.40 (more lenient)

Unlike AFFX, PTCT (biopharmaceutical, very speculative) has not activated its pattern but I have been watching it make a flag just below resistance over the last several days.  A break above 35 targets 45, which is a logical resistance point with the SMA 200 right there.


Buy Target:  30 to 35 (a wide range, but since it has not exceeded the neckline a drop to the EMAs 50 and 20 is not out of the question).

Sell Target:  45 or anywhere lower.

Stop Loss:  Below SMA 50 (29).

A reminder that chart based NFTRH+ updates are technical trade setup ideas, which may not be revisited as the buy, sell, stop parameters are already noted. They are meant as a starting point for further research if interested. I will not personally buy every item highlighted and will sometimes sell – without prior notice (because this takes time and resource away from NFTRH’s main functions) – any item that I do buy, below target, which is something I often do as a trader. Also please be aware that I am not a fundamental stock analyst. Due diligence is your responsibility.